» Articles » PMID: 30761886

The Role of IFIH1 Gene Rs1990760 and Rs2111485 Single-nucleotide Polymorphisms in Generalized Vitiligo Predisposition

Overview
Journal Turk J Med Sci
Specialty General Medicine
Date 2019 Feb 15
PMID 30761886
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Interferon-induced helicase (IFIH1) is a gene locus that has been recently defined as a candidate for susceptibility to generalized vitiligo (GV). The objectives of this study were to assess the association of IFIH1 gene, rs2111485, and rs1990760 single-nucleotide polymorphisms (SNP) with susceptibility to GV and the autoimmune diseases accompanying GV.

Materials And Methods: We prospectively studied GV patients and frequency-matched healthy controls by age and sex. The genotypes of the participants were determined for rs1990760 and rs2111485 SNPs of IFIH1. Dominant, recessive, and additive models were evaluated for each SNP adjusted for age and sex.

Results: The patients and their controls were observed to be in the Hardy–Weinberg equilibrium for SNP1 (2q24.2, rs1990760, IFIH1, T/C) and SNP2 (2q24.2, rs2111485, IFIH1, G/A), respectively (all P > 0.7). For SNP1, every T allel addition was significantly associated with 1.53 times protectiveness in terms of vitiligo risk (P = 0.033). As for SNP2, every G allel addition was associated with 1.42 times protectiveness, close to statistical significance (P = 0.100).

Conclusions: We detected that for SNP1, each T allel and for SNP2, each G allel are protective in terms of vitiligo development. Hereby, we confirmed that IFIH1 gene locus has a role in GV susceptibility.

Citing Articles

Association Among , and Gene Polymorphisms and Non-Segmental Vitiligo in a Chinese Han Population.

Wang D, Min S, Lin X, Jiang G Clin Cosmet Investig Dermatol. 2022; 15:1597-1609.

PMID: 35983127 PMC: 9380431. DOI: 10.2147/CCID.S369418.


Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population.

Zapata-Salazar N, Kubelis-Lopez D, Salinas-Santander M, Sanchez-Dominguez C, Xolalpa-Rosales A, Gomez-Galindo M Arch Dermatol Res. 2022; 315(3):447-454.

PMID: 35960353 DOI: 10.1007/s00403-022-02382-8.

References
1.
Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim H, Hamzavi I . Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. J Am Acad Dermatol. 2015; 74(2):295-302. DOI: 10.1016/j.jaad.2015.08.063. View

2.
Yin X, Low H, Wang L, Li Y, Ellinghaus E, Han J . Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun. 2015; 6:6916. PMC: 4423213. DOI: 10.1038/ncomms7916. View

3.
Shigemoto T, Kageyama M, Hirai R, Zheng J, Yoneyama M, Fujita T . Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem. 2009; 284(20):13348-13354. PMC: 2679434. DOI: 10.1074/jbc.M809449200. View

4.
Spritz R . Recent progress in the genetics of generalized vitiligo. J Genet Genomics. 2011; 38(7):271-8. PMC: 3513342. DOI: 10.1016/j.jgg.2011.05.005. View

5.
Spritz R . The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 2007; 20(4):271-8. DOI: 10.1111/j.1600-0749.2007.00384.x. View